Predictive Oncology Inc. — Director's Dealing 2016

Mar 30, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2016-03-24

Reporting Person: Schwartz Carl I. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1654312	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant	$3.75	2018-03-12	Common Stock (56381)		Direct
Stock Options (right to buy)	$11.25	2023-07-19	Common Stock (1778)		Direct
Stock Options (right to buy)	$3.10	2025-06-30	Common Stock (6452)		Direct
Stock Options (right to buy)	$3.10	2025-06-30	Common Stock (6452)		Direct

Footnotes

F1: Currently exercisable.